Luxembourg Country Drug Report 2019

Drug markets

The majority of illicit substances consumed in Luxembourg arrive from the Netherlands (cannabis and other drugs), Belgium (MDMA/ecstasy and amphetamine-type stimulants) and Morocco (cannabis resin). Cocaine found on the national market originates from Latin America and enters Luxembourg via the south of Europe. Heroin is trafficked into the country via the traditional Balkan route, more specifically its northern branch.

In recent years, an increasing number of organised criminal distribution networks have developed nationally, contributing to a rise in drug availability, particularly in the supply of cocaine and cannabis. In addition, organised crime groups from Western African countries are developing large-scale cocaine trafficking activities throughout Europe, including Luxembourg.

Following a reduction in quantities of heroin seized in 2012, as reported in other European countries, the annual amounts seized have recently been increasing, although they remain comparatively small. No clear trends are evident from these data in respect to cannabis — either herb or resin — or cocaine.

The reported number of heroin seizures has been generally stable since 2000 (ranging from 127 to 292 annually between 2000 and 2016), although in 2017 only 69 seizures were reported. Seizures of cocaine have increased steadily since 2000 (from 51 in 2000 to 222 in 2017). In recent years, an increase in seizures of both cannabis resin and herbal cannabis has been observed. The total number of annual MDMA seizures has also been increasing.

New psychoactive substances are seized occasionally in Luxembourg, and in small quantities, indicating that they are intended for individual use.

Data on the retail price and purity of the main illicit substances seized are shown in the ‘Key statistics’ section.

#


Luxembourg main page

Methodological note: Analysis of trends is based only on those countries providing sufficient data to describe changes over the period specified. The reader should also be aware that monitoring patterns and trends in a hidden and stigmatised behaviour like drug use is both practically and methodologically challenging. For this reason, multiple sources of data are used for the purposes of analysis in this report. Caution is therefore required in interpretation, in particular when countries are compared on any single measure. Detailed information on methodology and caveats and comments on the limitations in the information set available can be found in the EMCDDA Statistical Bulletin.